Khiron Life Sciences Corp.

Latest

Aug 10, 2020, 08:50 ET Khiron Signs First Kuida™ Distribution Deal in Hong Kong

Breakthrough Agreement Brings CBD Skincare Brand to World Leading Asia Pacific Market Kuida CBD skincare products to be distributed through pharmacy, beauty retail and online markets serving the Hong ...


Jul 27, 2020, 06:55 ET Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and...


Jul 23, 2020, 06:55 ET Khiron to Commercialize Medical Cannabis in Peru

Khiron has received all necessary licenses and authorizations allowing full spectrum, high-CBD medical cannabis products to be exported from Colombia for import and commercialization in Peru Full...


Jul 17, 2020, 06:55 ET Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour

Attendees are invited to attend a real-time, interactive tour of Khiron's recently completed Zerenia medical facility TORONTO, July 17, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the...


Jul 02, 2020, 07:00 ET Khiron Expands EU Footprint, Signing Kuida™ Distribution Deal in Spain

Kuida CBD skincare products to be distributed through 2,350 stores across four drug store health and beauty distributor groups in Spain Deal with Red Yellow Red, a leading cosmetic products master...


Jun 25, 2020, 10:05 ET Khiron Signs Distribution Deal in Germany for Medical Cannabis Imports and Sales

Khiron partners with Nimbus Health, a leading medical cannabis distributor in Germany, with broad reach into domestic pharmacies First import and sales of Khiron branded EU GMP medical cannabis...


Jun 24, 2020, 07:00 ET /C O R R E C T I O N from Source -- Khiron Life Sciences Corp./

In the news release, Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia, issued 24-Jun-2020 by Khiron Life Sciences Corp. over CNW, we are advised by the company that the second...


Jun 22, 2020, 07:00 ET Khiron CEO and Board Chair to Participate in Live Webcast on June 24th

Individual and institutional investors, as well as advisors and analysts are invited to attend a real-time, interactive presentation on VirtualInvestorConferences.com TORONTO, June 22, 2020 /CNW/ -...


Jun 12, 2020, 16:00 ET Khiron Appoints Chris Naprawa to Director, and Chairman of the Board

TORONTO, June 12, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations...


May 28, 2020, 16:05 ET Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results

Closed quarter with net working capital of $28.4 million Achieved revenues of $1.9 Million for Q1 2020, improving gross margin by 17% compared to Q1 2019 Achieved first sales in Colombia of low-THC...


May 20, 2020, 00:05 ET Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

Khiron is the first company to receive authorization to commercialize high-THC medical cannabis magistral preparations from Colombia's National Narcotics Fund Authorization is supplementary to the...


May 07, 2020, 16:05 ET Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference

TORONTO, May 7, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in...


May 06, 2020, 00:01 ET Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

Khiron is the exclusive Latin American supplier to Project Twenty21, a leading UK registry study enrolling up to 20,000 patients by the end of 2021, to create the largest body of evidence in Europe...


May 01, 2020, 18:05 ET Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update

Net working capital of $36.4 Million CAD at December 31, 2019 On March 20, 2020 Khiron became the first and only company in Colombia to receive full authorization to manufacture high- and low-THC...


Apr 30, 2020, 16:01 ET Khiron Signs Exclusive Agreement with Medlive, a Distributor Serving 3,000 Clinics and Hospitals in Brazil

Exclusive agreement with Medlive, a pharmaceutical and health products distributor with network of over 3,000 clinics and hospitals in southern Brazil Company's medical cannabis products will be...


Apr 28, 2020, 07:00 ET Khiron Provides Update on Filing of its 2019 Year End Results

Company filing date moved from April 29 to estimate of May 1 to allow auditors to complete audit delayed as a result of COVID-19 situation Filing extension provided by Ontario Securities Commission...


Apr 22, 2020, 00:01 ET Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel

Khiron's medical cannabis products to be carried at Locatel's large-format pharmacy locations in Colombia Locatel is an important pharmacy, healthcare products and medical equipment retailer in...


Apr 03, 2020, 07:50 ET Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update

Khiron to report Q4 and Year End Results on April 28, and webcast Q&A will be held the following day Khiron finished the 2019 calendar year with approximately $36 Million CAD in cash and working...


Mar 31, 2020, 18:56 ET Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University

Agreement with Tecnologico de Monterrey, a leading Latin American university (Third Ranked in Latin America) in Mexico brings Khiron´s online education program to reach 1,500 physicians, healthcare...


Mar 30, 2020, 20:21 ET Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia

Starting April 1st, Company's virtual consultation service gives patients access to clinic services and doctors trained to prescribe medical cannabis Teleconsultation service anticipated to quickly...


Mar 20, 2020, 08:48 ET Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update

Effective immediately, Khiron is fully authorized to manufacture high- and low-THC medical cannabis, and to fill prescriptions for low-THC medical cannabis Khiron anticipates filling its first...


Mar 05, 2020, 18:36 ET Khiron Poised to Enter Medical Cannabis Market in Peru

Signed a 2-year exclusive agreement to manufacture and distribute Khiron-branded medical cannabis products in Lima, Peru´s largest city with 8.6 million inhabitants With 10 locations in Lima,...


Mar 01, 2020, 20:56 ET Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia

Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority ("TQG") allows the Company to now produce oils for sale both domestically...


Feb 27, 2020, 19:21 ET Khiron Receives Approval of Normal Course Issuer Bid

TORONTO, Feb. 27, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), a vertically integrated cannabis leader with core operations in Latin America, is...


Feb 26, 2020, 17:53 ET Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17% of the Total Allocated Quota for Colombia in 2020

Colombia was granted a total production quota of 56.2 tons of medical cannabis for 2020 by the International Narcotics Control Board ("INCB"), the entity responsible for the implementation of the...